A carregar...
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia
INTRODUCTION: High-dose methylprednisolone (HDMP) in combination with rituximab is active in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL), but serious infections are frequent. Recently published data suggested that high-dose dexamethasone might be equally effective as HDMP...
Na minha lista:
| Publicado no: | Arch Med Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4848354/ https://ncbi.nlm.nih.gov/pubmed/27186190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2016.55425 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|